Radisson Mining Believes Small Is Beautiful, For Now
Source: Brian Sylvester of The Gold Report  (1/12/15)
It is good to know what you are and what you are not. Radisson Mining Resources Inc. knows what it is—a small gold exploration company with aims of becoming a small gold producer inside 28 months. Radisson Mining President and CEO Mario Bouchard believes his company has a realistic plan in place to reach its goal and it's just a matter of focus and execution. Bouchard explains his plan and his company's identity in this interview with The Gold Report.
More >

Despite Lifting Rare Earths Export Quotas, China Could Still Manipulate Market
Source: Henry Lazenby, Mining Weekly  (1/9/15)
"The rare earths industry was in a state of consolidation after a Chinese export clampdown prompted a rapid spike in prices in 2010/11." More >

Revolutionary Oil Prospector Richard Masterson Shares Fracking Investment Opportunities Gov. Cuomo Can't Touch
Source: George S. Mack of The Energy Report  (1/8/15)
Richard "Rich" Masterson, a Midland, Texas-based consulting geologist, has helped originate oil and gas projects with previously unseen potential. In this interview with The Energy Report, Masterson describes the significance of innovative science and new methods of prospecting to locate and liberate large amounts of energy, regardless of NIMBY politics like those playing out in New York State. He also brings projects and companies with potential upside for investors to the surface. More >

Where Do Cures Reside? Morrie Ruffin and Michael Werner of the Alliance for Regenerative Medicine Think the Answer Is in Regenerative Medicine
Source: George S. Mack of The Life Sciences Report  (1/8/15)
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones—and investors in the space should strap in for a rewarding joy ride. In this interview with The Life Sciences Report, Alliance for Regenerative Medicine cofounders Morrie Ruffin and Michael Werner consider how new federal guidance might enable new standards of care in cardiovascular, neurologic and oncologic medicine, and offer a preview of next week's Biotech Showcase in San Francisco. More >

Where Do Cures Reside? Morrie Ruffin and Michael Werner of the Alliance for Regenerative Medicine Think the Answer Is in Regenerative Medicine
Source: George S. Mack of The Life Sciences Report  (1/8/15)
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones—and investors in the space should strap in for a rewarding joy ride. In this interview with The Life Sciences Report, Alliance for Regenerative Medicine cofounders Morrie Ruffin and Michael Werner consider how new federal guidance might enable new standards of care in cardiovascular, neurologic and oncologic medicine, and offer a preview of next week's Biotech Showcase in San Francisco. More >

The Look and Feel of Canadian Venture Market Bottoms
Source: Visual Capitalist  (1/8/15)
"While it is difficult to discern if today’s market is truly the absolute bottom, the similarities in media headlines, the tone of discussion, and overall sentiment are reminiscent of bear markets past." More >

Medical Marijuana Goes to Market: Daniel Pearlstein of M Partners
Source: George S. Mack of The Life Sciences Report  (1/7/15)
Life sciences analyst Daniel Pearlstein of Toronto-based M Partners brings knowledge of the biotech sector and hands-on experience in the startup realm to understanding value and growth in small- and micro-cap life sciences companies. In this interview with The Life Sciences Report, Pearlstein offers his perspectives on six Canadian biotech and specialty pharma names with different value propositions and the capacity to grow multiples of invested capital, including one company in the budding medical marijuana field.
More >

Will the January Effect Give Gold and Silver Miners a Bounce?
Source: JT Long of The Gold Report  (1/7/15)
The January Effect–the surge that small-cap companies may experience at the beginning of the year–goes back some seven decades. What will 2015 bring? The Gold Report talked to some experts to find out what they are expecting in the early days of the new year and which companies might be in position to take advantage. Most experts are optimistic about a bump, and some have some very interesting ways to profit from it. More >

Gold Shrugs Off Dollar-Bullish US Jobs Data, Eurozone Uncertainty
Source: Adrian Ash, Bullion Vault  (1/7/15)
"Euro-priced gold meantime extended yesterday's surge, hitting a new 16-month high above €1,029 per ounce after news that Eurozone inflation fell to minus 0.2% across the 19-nation union in December, pulled down by falling oil prices." More >

Are You Ready for the January Effect?
Source: JT Long of The Mining Report  (1/6/15)
As far back as 1942, economists have noted that small-cap companies in particular tend to surge at the beginning of the year in a cycle known as the January Effect. After the year we have seen in the natural resources space, The Mining Report checked in with sector experts to find out whether they are expecting this traditional gift, how they are preparing for it and what companies could benefit. More >

Brent Cook: Investing During the Era of Peak Gold Discoveries
Source: JT Long of The Gold Report  (1/5/15)
We've hit peak economic gold discoveries, but unlike the new fracking technologies that saved the oil industry, there's no fracking technology to coax mineral wealth from ever-deeper deposits. In the face of this shortage, expert geologist Brent Cook of Exploration Insights is scouting out companies that are cashed up and poised to deliver value when other miners may be left scraping the bottom of the barrel. In this interview with The Gold Report, find out what Cook expects for gold exploration in 2015, and why the next few years are going to be very interesting indeed for yellow metal miners. More >

Gold Great Value Protector in 2014, Silver Not
Source: Lawrence Williams, Mineweb  (1/5/15)
"If one looks at the strength of the US dollar (or perhaps this should be the weakness of other currencies vs the dollar) with the dollar index rising 12.4% over the year, an investment in gold in any other currency will have seen a decent increase over the year." More >

Lithium in 2015: Positioning for the Inflection Point
Source: Chris Berry, Disruptive Discoveries Journal  (1/5/15)
"With an overall growth rate of demand of 8% for lithium, even if demand falters somewhat and averages 6%, this is still double global GDP growth rate estimates, offering a buffer against economic headwinds." More >

The Miracle that Would Have Saved Superman
Source: Ray Blanco, The Daily Reckoning  (1/2/15)
"This technology has been in development for a long time, but things are moving fast. Stem cells are simply too important for an investor to ignore in 2015." More >

The Four Exploration Companies Bottomfisher John Kaiser Thinks Could Get Gold Investors Excited Again
Source: JT Long of The Gold Report  (12/31/14)
The junior resource market is at a historic low point, but Kaiser Research Online author John Kaiser knows it just takes one big discovery to bring excitement—and investor dollars—back to the market. It has happened before. In this interview with The Gold Report, he reveals which four companies could lead the way. More >

Resolve to Do Better in 2015: Expert Edition
Source: JT Long of The Gold Report  (12/31/14)

As natural resource investors take stock of their 2014 portfolio shifts and make adjustments for 2015, The Gold Report quizzed top experts in the sector on what resolutions they are making and—perhaps more important—what steps they are taking to make sure they stick to the hard choices they have made. We want to know if you are taking the same steps, have your own plan to make the most of whatever happens in the sector or just plain disagree. Please use the comment section to let us know what you will be investing in as we bravely face a new year.
More >

Chris Berry Identifies Commodity Companies with the Disruptive Advantage
Source: JT Long of The Mining Report  (12/30/14)
Globetrotting Chris Berry, founder of House Mountain Partners, finds most retail and institutional investors sitting on the sidelines waiting to see where the energy sector is headed before jumping back into the game. Game-changing disruptive technologies or sustainable end-user agreements are what companies need to succeed and he shares some likely names in the cobalt, lithium, nickel, graphite—even uranium—spaces in this interview with The Mining Report. More >

Will Biotech Fire on All Cylinders in 2015?
Source: Tracy Salcedo-Chourré of The Life Sciences Report  (12/30/14)
Making predictions for the New Year may feel as productive as peering into a crystal ball. But in the life sciences, hard science and long experience back prognostication. The biotech market enjoyed a stellar 2013 and withstood a solid check in early 2014 before rebounding, essentially following the upward trend that most experts forecast. What is in store for 2015? The Life Sciences Report turned to newsletter writer John McCamant and WBB Securities' Steve Brozak for insight. More >

Gold Beat All Other World Currencies in 2014
Source: Frank Holmes, U.S. Global Investors  (12/30/14)
"Even though gold has lost 0.8 percent year-to-date as of this writing, it still leads all major world currencies except for the U.S. dollar." More >

Aussie Toe Cutters Girding Companies for the Long Haul
Source: Brian Sylvester of The Gold Report  (12/29/14)
In Australia, when companies want to cut costs, they hire what are known as "toe cutters." These managers root out inefficiency and drive profitability. Vincent Pisani, senior resources analyst with Shaw Stockbroking in Sydney, Australia, says toe cutters down under are girding companies by lowering production costs to ensure profitable operations even in the face of further commodity price weakness. In this interview with The Gold Report, Pisani suggests some companies that are well positioned to succeed, even if their toes are somewhat shorter than they used to be. More >

Poised to Bounce Back? Gold and Silver Prices in 2015
Source: Peter Krauth, Money Morning  (12/29/14)
Will 2014 eventually prove to define the bottom in gold? The odds of that are improving. More >

BioWorld's Top 10: Biggest Biotech News Makers and Stories of 2014
Source: BioWorld  (12/29/14)
To say that 2014 was a good year for the biopharma industry would be a radical understatement. The flourishing capital markets, the record-breaking number of companies successfully going public via initial public offerings and the validation of scientific breakthroughs that only a few years ago had been mere theories all made for a banner year for the sector More >

Best of the Best: The Most Popular Thoughts from 2014
Source: JT Long of The Gold Report  (12/24/14)
As natural resources bounced all over the charts in 2014, readers turned to the experts interviewed by The Gold Report for insights on what was driving these ups and downs, and how they could protect themselves—or, better yet, benefit—from the volatility. We combed through interviews with experts featured during the year, and offer some thoughts you might want to consider as you prepare for 2015. More >

8 Billion Reasons to Invest in Potash: Paradigm's Spencer Churchill
Source: JT Long of The Energy Report  (12/23/14)
Potash producers have 8 billion reasons why demand for the minerals that increase food production will grow in the coming decades. Plus, a sinkhole emerging under a Russian mine is raising questions about the ability to produce enough fertilizer to feed what is projected to be an even larger and more demanding global population. The right companies could reap the benefits of exposure to the agricultural market. In this interview with The Mining Report, Paradigm Capital Analyst Spencer Churchill shares some of his favorites and talks about a unique streaming model that benefits from immediate upside. More >

Cell Therapy 2015: With Maturity Comes Promise
Source: Tracy Salcedo-Chourré of The Life Sciences Report  (12/23/14)
A number of new and innovative medical paradigms are being explored by companies in the life sciences sector, with one of the front-runners being cell therapy—a disruptive technology that has, in the past few years, progressed out of preclinical studies and into clinical development. To learn more about the transformative promise of regenerative medicine, and what investors might expect from companies working in the sector in 2015, The Life Sciences Report asked analysts Jason Kolbert of Maxim Group and Dr. Christopher James of Brinson Patrick to discuss the advances that could generate robust returns on investment in coming years. More >